07: Streptococcus Flashcards
Give a general descripton of streptococci/enterococci.
- Pyogenic (pus forming) pathogens
- Nonmotile,non-spore forming, mostly facultatively anaerobic, catalase negative, GPC in chains
- Enterococci established as separate species based on DNA homology studies
For s. pneumoniae:
- Sites of colonization
- Sites of infection
- Diseases
- Treatment
- Oropharynx, nose
- Lungs, sinuses, middle ear, meninges
- Pneumonia, otitis media, sinusitis, infant/adult meningitis
- PCN (3GC if resistant; vancomycin/levofloxacin if highly resistant)
For s. pyogenes (GAS):
- Sites of colonization
- Sites of infection
- Diseases
- Treatment
- Oropharynx, rectum
- Pharynx, skin, soft tissue
- Pharyngitis (strep throat), TSS, impetigo, rheumatic fever, pyoderma
- PCN/Amox; Macrolides/1GC if allergic
For enterococcal spp.:
- Sites of colonization
- Sites of infection
- Diseases
- Treatment
- GI tract
- Urinary and biliary tract, cardiac valves
- Acute bacterial prostatitis, endocarditis, neonatal meningitis
- PCN/Amp; if resistant, vanco; if endocarditis, aminoglycoside for synergy; if vanco resistant (VRE), linez/dapto/streptogramin
For s. agalactiae (GBS):
- Sites of colonization
- Sites of infection
- Diseases
- Treatment
- GU tract
- Neonatal infections involving blood, meninges, GU tract
- Neonatal miningitis, sepsis
- PCN/amox; macrolides/1GC if allergic
For viridans streptococci:
- Sites of colonization
- Sites of infection
- Diseases
- Treatment
- Oropharynx
- Cardiac valves, bloodstream
- Endocarditis
4.
Describe the hemolysis patterns of strep.
- S. pyogenes & agalactiae are beta (complete)
- Viridans & pneumoniae are alpha (partial)
- Enterococci are gamma (none)
Describe the disk patterns of strep.
- S. pneumoniae is the only optochin susceptible species.
- S. pyogenes (GAS) is the only bacitracin susceptible species.
Mnemonic: OVRPS & BBRAS
Describe the structural components of GAS.
- Hyaluronic acid capsule: interferes with phagocytosis.
- M protein: major virulence factor; interferes with phagocytosis (inhibits complement activation); implicated in pathogenesis of rheumatic fever.
- Protein F & lipoteichoic acid: mediate binding to fibronecting
- Protein G: binds Fc portion of immunoglobulin
Describe the secreted products of GAS.
- Enzymes
- Streptolysins O & S
- DNase, hyaluronidase, streptokinase: tissue breakdown, pus formation.
- Toxins
- Pyrogenic exotoxins (SPE A, B, C): produce superantigen-mediated TSS; responsible for scarlet fever.
Describe the clinical features of GAS pharyngitis.
- Epi: 5-15yo, winter/early spring
- Most common of the streptococcal infections, but only account for a small number of pharyngitis cases
- Sore throat, sudden onset, fever, pain with swallowing, headache, lymphadenitis, tonsillar exudates, soft palate petechiae
- Non-suggestives: conjuctivitis, coryza (nasal discharge), cough, diarrhea
- Sequelae: abscess, sepsis, dissemination
- Diagnose using rapid strep kits (specific but not sensitive; treat if positive, confirm if negative), anti-streptolysin (ASO) test (reflects past, not present, infection)
Describe the nonsuppurative sequelae of pharyngitis.
-
Rheumatic fever: diagnose via Jones criteria:
- Joints (polyarthitis)
- Heart (carditis)
- Nodules (subcutaneous)
- Erythema marginatum (circular rash)
- Sydenham’s chorea (jerking movements)
- Glomerulonephritis: renal disease by strep antigens deposited in glomerular membrane.
Mnemonic: Pharyngitis can result in phever and glomerulonephritis.
Describe the clinical features of impetigo.
- Rash on face
- Small pustules that progress to thick honey-crusted lesions
- Large primary lesion and several satellite lesions
- Commonly results from GAS or S. aureus
- Complications rare: lymphadenitis, immune-complex glomerulonephritis
Describe the clinical features of streptococcal toxic shock syndrome.
- Pyrogenic exotoxins A-C implicated
- Superantigen-mediated
- Differs from S. aureus TSS because of frequent presence of infections
- Necrotizing fascitis linked w/ specific M types
Describe the treatment/prevention of s. pyogenes infections.
- Penicillin
- Protein synthesis inhibitors (e.g., clindamycin) may improve outcome
- Macrolide-resistance emerging
- Vaccines under development (type-specific epitopes or highly conserved regions of M protein; target proteins mediating epithelial adherence)